Workshop on molecular targets for Cancer

The European Commission (DG RTD, CRP Santé) is organising a workshop on molecular targets for cancer on 6-7 October 2006 in Abbaye de Neumünster, Luxembourg.

With an estimated 2.9 million new cases and 1.7 million deaths each year, cancer remains an important public health problem in Europe. In addition, the ageing of the European population will cause these numbers to continue to increase even if age-specific rates remain constant.

The discovery of novel molecular targets for several of the most frequent cancers to date (lung, breast, colorectal, stomach, prostate, pancreatic and bladder cancer) will enable diagnosis at earlier stages of the disease. This will lead to early identification of patients needing treatment, and will have a profound impact on treatment selection for individual patients. In addition, cancer biomarkers may have the potential to serve as targets for the development of new anti-cancer therapies and innovative treatment strategies. Finally, accurate prognostic markers will be useful in assessing the risk of developing metastasis, and will empower the clinician in making decisions about the best possible targeted therapy for the benefit of the patient.

However, Europe's research and development efforts have so far been fragmented and have suffered from the lack of a coherent, strategic vision in translating all this basic knowledge into successful applications and therapies. The aim of this workshop is to identify possible bottlenecks and put forward solutions that boost the commercial value of potentially innovative findings on molecular targets, emanating from European research on cancer.

For further information, please visit:
www.ccrn.lu/cancer/

Most Popular Now

Most Advanced Artificial Touch for Brain…

For the first time ever, a complex sense of touch for individuals living with spinal cord injuries is a step closer to reality. A new study published in Science, paves...

Picking the Right Doctor? AI could Help

Years ago, as she sat in waiting rooms, Maytal Saar-Tsechansky began to wonder how people chose a good doctor when they had no way of knowing a doctor's track record...

From Text to Structured Information Secu…

Artificial intelligence (AI) and above all large language models (LLMs), which also form the basis for ChatGPT, are increasingly in demand in hospitals. However, patient data must always be protected...

Deep Learning Model Helps Detect Lung Tu…

A new deep learning model shows promise in detecting and segmenting lung tumors, according to a study published in Radiology, a journal of the Radiological Society of North America (RSNA)...

AI Innovation Unlocks Non-Surgical Way t…

Researchers have developed an artificial intelligence (AI) model to detect the spread of metastatic brain cancer using MRI scans, offering insights into patients’ cancer without aggressive surgery. The proof-of-concept study, co-led...

New Study Reveals AI's Transformati…

Intensive care units (ICUs) face mounting pressure to effectively manage resources while delivering optimal patient care. Groundbreaking research published in the INFORMS journal Information Systems Research highlights how a novel...

One of the Largest Global Surveys of Soc…

As leaders gather for the World Economic Forum Annual Meeting 2025 in Davos, Leaps by Bayer, the impact investing arm of Bayer, and Boston Consulting Group (BCG) announced the launch...

New Computer Models Open Door to Far Mor…

With antibiotic resistance a growing problem, University of Virginia School of Medicine researchers have developed cutting-edge computer models that could give the disease-fighting drugs a laser-like precision to target only...

New Biomarkers to Detect Colorectal Canc…

Machine learning and artificial intelligence (AI) techniques and analysis of large datasets have helped University of Birmingham researchers to discover proteins that have strong predictive potential for colorectal cancer. In a...

Sam Neville Joins the Highland Marketing…

Leading chief nursing information officer Sam Neville is joining the Highland Marketing advisory board. Sam brings a passion for nursing and safety to the board, which debates the big issues...

AI Model Identifies Potential Risk Genes…

Researchers from the Cleveland Clinic Genome Center have successfully applied advanced artificial intelligence (AI) genetics models to Parkinson's disease. Researchers identified genetic factors in progression and FDA-approved drugs that can...

AI Tool that may Assist Underserved Hosp…

As the fields of healthcare and technology increasingly evolve and intersect, researchers are collaborating on the best ways to use emerging technologies such as artificial intelligence (AI) to care for...